Find Zileuton manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

Annual Reports

NA

Finished Drug Prices

NA

210 RELATED EXCIPIENT COMPANIES

376EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 111406-87-2, Zyflo, Leutrol, 1-(1-(benzo[b]thiophen-2-yl)ethyl)-1-hydroxyurea, Zileutonum, Abbott 64077
Molecular Formula
C11H12N2O2S
Molecular Weight
236.29  g/mol
InChI Key
MWLSOWXNZPKENC-UHFFFAOYSA-N
FDA UNII
V1L22WVE2S

Zileuton
Zileuton is a synthetic derivative of hydroxyurea with antiasthmatic properties. The leukotriene inhibitor zileuton blocks 5-lipoxygenase, which catalyzes the formation of leukotrienes from arachidonic acid; causes bronchodilation; decreases bronchial mucous secretion and edema; and may prevent or decrease the symptoms of asthma. (NCI04)
Zileuton is a 5-Lipoxygenase Inhibitor. The mechanism of action of zileuton is as a 5-Lipoxygenase Inhibitor. The physiologic effect of zileuton is by means of Decreased Leukotriene Production.
1 2D Structure

Zileuton

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea
2.1.2 InChI
InChI=1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14)
2.1.3 InChI Key
MWLSOWXNZPKENC-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O
2.2 Other Identifiers
2.2.1 UNII
V1L22WVE2S
2.3 Synonyms
2.3.1 MeSH Synonyms

1. A 64077

2. A-64077

3. Abbot 64077

4. N-(1-benzo(b)thien-2-ylethyl)-n-hydroxyurea

5. Zyflo

2.3.2 Depositor-Supplied Synonyms

1. 111406-87-2

2. Zyflo

3. Leutrol

4. 1-(1-(benzo[b]thiophen-2-yl)ethyl)-1-hydroxyurea

5. Zileutonum

6. Abbott 64077

7. Zileutonum [inn-latin]

8. 1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea

9. A-64077

10. N-(1-benzo(b)thien-2-ylethyl)-n-hydroxyurea

11. A 64077

12. Zyflo (tn)

13. Abbott-64077

14. Urea, N-(1-benzo[b]thien-2-ylethyl)-n-hydroxy-

15. Chembl93

16. 1-[1-(1-benzothien-2-yl)ethyl]-1-hydroxyurea

17. Nsc-730712

18. Nsc-759277

19. N-[1-(benzo[b]thiophen-2-yl)ethyl]-n-hydroxyurea

20. V1l22wve2s

21. (+-)-1-(1-benzo(b)thien-2-ylethyl)-1-hydroxyurea

22. (+/-)-1-(1-benzo[b]thien-2-ylethyl)-1-hydroxyurea

23. Zyflo Cr

24. Chebi:10112

25. N-(1-benzo[b]thien-2-ylethyl)-n-hydroxyurea

26. (+-)-1-(1-benzo[b]thien-2-ylethyl)-1-hydroxyurea

27. N-(1-benzo(b)thien-2-yl-ethyl)-n-hydroxyurea

28. Ncgc00159453-02

29. Dsstox_cid_3752

30. Dsstox_rid_77185

31. Dsstox_gsid_23752

32. Urea, N-(1-benzo(b)thien-2-ylethyl)-n-hydroxy-

33. Ziluton

34. Zyflo Filmtab

35. ( Inverted Exclamation Marka)-1(1-benzo[b]thien-2-ylethyl)-1-hydroxyure

36. Smr000466377

37. Cas-111406-87-2

38. Zileuton (usp/inn)

39. Sr-01000759349

40. (+/-)-1-(1-benzo(b)thien-2-ylethyl)-1-hydroxyurea

41. Unii-v1l22wve2s

42. Cti-02

43. Abt-077

44. Zileuton [usan:usp:inn:ban]

45. Zileuton- Bio-x

46. Mfcd00866097

47. Starbld0016861

48. Zileuton [usan]

49. Zileuton [inn]

50. Zileuton [mi]

51. Zileuton [vandf]

52. Prestwick0_001090

53. Zileuton [mart.]

54. Zileuton [usp-rs]

55. Zileuton [who-dd]

56. Schembl4209

57. Mls000759510

58. Mls001424079

59. Mls006011971

60. Zileuton [orange Book]

61. Gtpl5297

62. Zileuton, >=98% (hplc)

63. Dtxsid9023752

64. Schembl18251470

65. Zileuton [usp Monograph]

66. Urea, N-(1-benzo(b)thien-2-ylethyl)-n-hydroxy-, (+-)-

67. Hms2051m20

68. Hms2089j12

69. Hms2093h06

70. Hms2235o04

71. Hms3369i17

72. Hms3393m20

73. Hms3654j08

74. Hms3714e07

75. Hms3872f13

76. Pharmakon1600-01505906

77. Amy12540

78. Bcp16199

79. Tox21_111680

80. Tox21_301148

81. Bbl029070

82. Bdbm50000541

83. Nsc730712

84. Nsc759277

85. S1443

86. Stl373010

87. Akos000280127

88. Akos016340558

89. Tox21_111680_1

90. Ccg-100901

91. Ccg-213571

92. Cs-1563

93. Db00744

94. Ks-1195

95. Nc00151

96. Nsc 730712

97. Nsc 759277

98. Sb19083

99. Mrf-0000030

100. Ncgc00159453-03

101. Ncgc00159453-04

102. Ncgc00159453-05

103. Ncgc00159453-06

104. Ncgc00255046-01

105. Ac-13198

106. Ac-31490

107. Bz164573

108. Hy-14164

109. Sbi-0206869.p001

110. Db-015071

111. Bb 0261152

112. Ft-0601582

113. Ft-0675903

114. Sw197531-3

115. 1-(1-benzothiophen-2-ylethyl)-1-hydroxy-urea

116. D00414

117. N-(1-benzo[b]thien-2-ylethyl)-n-hydroxy-urea

118. Ab00639921-06

119. Ab00639921-08

120. Ab00639921-09

121. Ab00639921_10

122. Ab00639921_11

123. 406z872

124. A802357

125. Q202998

126. J-002574

127. J-525169

128. Sr-01000759349-4

129. Sr-01000759349-5

130. Sr-01000759349-6

131. Zileuton, Commercially Available As 600 Mg Tablets

132. Brd-a56359832-001-04-6

133. Z1551429725

134. Zileuton, United States Pharmacopeia (usp) Reference Standard

135. Urea, N-(1-benzo(b)thien-2-ylethyl)-n-hydroxy-, (+/-)-

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 236.29 g/mol
Molecular Formula C11H12N2O2S
XLogP31.6
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count3
Rotatable Bond Count2
Exact Mass236.06194880 g/mol
Monoisotopic Mass236.06194880 g/mol
Topological Polar Surface Area94.8 Ų
Heavy Atom Count16
Formal Charge0
Complexity275
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 4  
Drug NameZyflo
PubMed HealthZileuton (By mouth)
Drug ClassesAnti-Inflammatory
Drug LabelZileuton is an orally active inhibitor of 5-lipoxygenase, the enzyme that catalyzes the formation of leukotrienes from arachidonic acid. Zileuton has the chemical name ()-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea and the following chemical struct...
Active IngredientZileuton
Dosage FormTablet
RouteOral
Strength600mg
Market StatusPrescription
CompanyChiesi Usa

2 of 4  
Drug NameZyflo cr
PubMed HealthZileuton (By mouth)
Drug ClassesAnti-Inflammatory
Drug LabelZileuton is an orally active inhibitor of 5-lipoxygenase, the enzyme that catalyzes the formation of leukotrienes from arachidonic acid. Zileuton has the chemical name ()-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea and the following chemical struct...
Active IngredientZileuton
Dosage FormTablet, extended release
RouteOral
Strength600mg
Market StatusPrescription
CompanyChiesi Usa

3 of 4  
Drug NameZyflo
PubMed HealthZileuton (By mouth)
Drug ClassesAnti-Inflammatory
Drug LabelZileuton is an orally active inhibitor of 5-lipoxygenase, the enzyme that catalyzes the formation of leukotrienes from arachidonic acid. Zileuton has the chemical name ()-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea and the following chemical struct...
Active IngredientZileuton
Dosage FormTablet
RouteOral
Strength600mg
Market StatusPrescription
CompanyChiesi Usa

4 of 4  
Drug NameZyflo cr
PubMed HealthZileuton (By mouth)
Drug ClassesAnti-Inflammatory
Drug LabelZileuton is an orally active inhibitor of 5-lipoxygenase, the enzyme that catalyzes the formation of leukotrienes from arachidonic acid. Zileuton has the chemical name ()-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea and the following chemical struct...
Active IngredientZileuton
Dosage FormTablet, extended release
RouteOral
Strength600mg
Market StatusPrescription
CompanyChiesi Usa

4.2 Drug Indication

For the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older.


FDA Label


5 Pharmacology and Biochemistry
5.1 Pharmacology

Zileuton is an asthma drug that differs chemically and pharmacologically from other antiasthmatic agents. It blocks leukotriene synthesis by inhibiting 5-lipoxygenase, an enzyme of the eicosanoid synthesis pathway. Current data indicates that asthma is a chronic inflammatory disorder of the airways involving the production and activity of several endogenous inflammatory mediators, including leukotrienes. Sulfido-peptide leukotrienes (LTC4, LTD4, LTE4, also known as the slow-releasing substances of anaphylaxis) and LTB4, a chemoattractant for neutrophils and eosinophils, are derived from the initial unstable product of arachidonic acid metabolism, leukotriene A4 (LTA4), and can be measured in a number of biological fluids including bronchoalveolar lavage fluid (BALF) from asthmatic patients. In humans, pretreatment with zileuton attenuated bronchoconstriction caused by cold air challenge in patients with asthma.


5.2 MeSH Pharmacological Classification

Anti-Inflammatory Agents, Non-Steroidal

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)


Lipoxygenase Inhibitors

Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES. (See all compounds classified as Lipoxygenase Inhibitors.)


Leukotriene Antagonists

A class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level. (See all compounds classified as Leukotriene Antagonists.)


5.3 FDA Pharmacological Classification
5.3.1 Active Moiety
ZILEUTON
5.3.2 FDA UNII
V1L22WVE2S
5.3.3 Pharmacological Classes
5-Lipoxygenase Inhibitors [MoA]; Decreased Leukotriene Production [PE]; 5-Lipoxygenase Inhibitor [EPC]
5.4 Absorption, Distribution and Excretion

Absorption

Rapidly and almost completely absorbed. The absolute bioavailability is unknown.


Route of Elimination

Elimination of zileuton is predominantly via metabolism with a mean terminal half-life of 2.5 hours. The urinary excretion of the inactive N-dehydroxylated metabolite and unchanged zileuton each accounted for less than 0.5% of the dose.


Volume of Distribution

1.2 L/kg


Clearance

Apparent oral cl=7 mL/min/kg


5.5 Metabolism/Metabolites

Hepatic. Zileuton and its N-dehydroxylated metabolite are oxidatively metabolized by the cytochrome P450 isoenzymes 1A2, 2C9 and 3A4.


Zileuton has known human metabolites that include Zileuton O-glucuronide.

S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560


5.6 Biological Half-Life

2.5 hours


5.7 Mechanism of Action

Leukotrienes are substances that induce numerous biological effects including augmentation of neutrophil and eosinophil migration, neutrophil and monocyte aggregation, leukocyte adhesion, increased capillary permeability, and smooth muscle contraction. These effects contribute to inflammation, edema, mucus secretion, and bronchoconstriction in the airways of asthmatic patients. Zileuton relieves such symptoms through its selective inhibition of 5-lipoxygenase, the enzyme that catalyzes the formation of leukotrienes from arachidonic acid. Specifically, it inhibits leukotriene LTB4, LTC4, LTD4, and LTE4 formation. Both the R(+) and S(-) enantiomers are pharmacologically active as 5-lipoxygenase inhibitors in in vitro systems. Due to the role of leukotrienes in the pathogenesis of asthma, modulation of leukotriene formation by interruption of 5-lipoxygenase activity may reduce airway symptoms, decrease bronchial smooth muscle tone, and improve asthma control.


EU WC

read-more
read-more

01

Pharma, Lab & Chemical Expo
Not Confirmed
arrow
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Zileuton USP

Date of Issue : 2019-10-07

Valid Till : 2022-07-02

Written Confirmation Number : WC-0226

Address of the Firm : D-24 and D24/1 MIDC Kurkumbh Tal. Daund, Dist Pune 413 802, Maharashtra State

blank

02

Pharma, Lab & Chemical Expo
Not Confirmed
arrow
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Zileuton USP

Date of Issue : 2022-06-17

Valid Till : 2025-07-14

Written Confirmation Number : WC-0021n

Address of the Firm : Sy. Nos: 317, 320, 321, 322, 323, 604 & 605, Rudraram (Village), Patancheru (Man...

blank

03

Pharma, Lab & Chemical Expo
Not Confirmed
arrow
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Zileuton USP

Date of Issue : 2020-07-23

Valid Till : 2023-05-11

Written Confirmation Number : WC-0273

Address of the Firm : Plot No. 34A, J.N.Pharma City, Thanam (V), Parawada (M), Vishakhapatnam-District...

blank

04

Pharma, Lab & Chemical Expo
Not Confirmed
arrow
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Zileuton USP

Date of Issue : 2022-09-30

Valid Till : 2025-08-04

Written Confirmation Number : WC-0127

Address of the Firm : A1/B, SIPCOT Industrial Complex, Kudikadu, Cuddalore-607 005

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"ZILEUTON","year":"2021","qtr":"Q1","strtotime":1609785000,"product":"ZILEUTON(GROUP:A)(TAX INV NO:1900206090 DT:25.11.2020","address":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR","city":"HYDERABAD, A.P.","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"NEW YORK","customer":"PAR PHARMACEUTICAL","customerCountry":"UNITED STATES","quantity":"100.30","actualQuantity":"100.3","unit":"KGS","unitRateFc":"933.3","totalValueFC":"94781","currency":"USD","unitRateINR":69112.5,"date":"05-Jan-2021","totalValueINR":"6931983.75","totalValueInUsd":"94781","indian_port":"HYDERABAD AIR","hs_no":"29242190","bill_no":"7704333","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR, HYDERABAD, A.P.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"ZILEUTON","year":"2021","qtr":"Q1","strtotime":1609785000,"product":"ZILEUTON(GROUP:A)(TAX INV NO:1900206234 DT:29.12.2020","address":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR","city":"HYDERABAD, A.P.","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"NEW YORK","customer":"PAR PHARMACEUTICAL","customerCountry":"UNITED STATES","quantity":"100.00","actualQuantity":"100","unit":"KGS","unitRateFc":"933.3","totalValueFC":"94497.5","currency":"USD","unitRateINR":69112.5,"date":"05-Jan-2021","totalValueINR":"6911250","totalValueInUsd":"94497.5","indian_port":"HYDERABAD AIR","hs_no":"29242190","bill_no":"7704331","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR, HYDERABAD, A.P.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"ZILEUTON","year":"2021","qtr":"Q1","strtotime":1612981800,"product":"ZILEUTON(GROUP:A)(TAX INV NO:1900206385 DT:29.01.2021","address":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR","city":"HYDERABAD, A.P.","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"NEW YORK","customer":"PAR PHARMACEUTICAL","customerCountry":"UNITED STATES","quantity":"100.00","actualQuantity":"100","unit":"KGS","unitRateFc":"950.7","totalValueFC":"94077.9","currency":"USD","unitRateINR":68495,"date":"11-Feb-2021","totalValueINR":"6849500","totalValueInUsd":"94077.9","indian_port":"HYDERABAD AIR","hs_no":"29242190","bill_no":"8560717","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR, HYDERABAD, A.P.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1641407400,"product":"ZILEUTON MSN - BATCH NO. 000029992","address":"OLD NO.1\/63, NEW NO.1\/58 PUDUPAKKAM","city":"","supplier":"PAR PHARMACEUTICAL","supplierCountry":"INDIA","foreign_port":"NEW YORK","customer":"ENDO VENTURES LIMITED","customerCountry":"UNITED STATES","quantity":"506.00","actualQuantity":"506","unit":"KGS","unitRateFc":"994.2","totalValueFC":"501087.9","currency":"USD","unitRateINR":73770.276679841903,"date":"06-Jan-2022","totalValueINR":"37327760","totalValueInUsd":"501087.9","indian_port":"Indore-EPZ\/SEZ","hs_no":"29349990","bill_no":"4000205","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Indore-EPZ\/SEZ","supplierAddress":"OLD NO.1\/63, NEW NO.1\/58 PUDUPAKKAM, ","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1706725800,"product":"ZILEUTON","address":"MSN HOUSE, PLOT NO. C-24,","city":"HYDERABAD. AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"NEWARK, NJ","customer":"STRIDES PHARMA SCIENCE","customerCountry":"UNITED STATES","quantity":"180.00","actualQuantity":"180","unit":"KGS","unitRateFc":"900","totalValueFC":"159723.6","currency":"USD","unitRateINR":73627.061111111107,"date":"01-Feb-2024","totalValueINR":"13252871","totalValueInUsd":"159723.6","indian_port":"Hyderabad Air","hs_no":"29242190","bill_no":"7195944","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"MSN HOUSE, PLOT NO. C-24,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708540200,"product":"ZILEUTON USP","address":"MSN HOUSE, PLOT NO. C-24,","city":"HYDERABAD. AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"ESKAYEF PHARMACEUTICAL LIMITED","customerCountry":"BANGLADESH","quantity":"1.50","actualQuantity":"1.5","unit":"KGS","unitRateFc":"1000","totalValueFC":"1440.2","currency":"USD","unitRateINR":79666.666666666672,"date":"22-Feb-2024","totalValueINR":"119500","totalValueInUsd":"1440.2","indian_port":"Hyderabad Air","hs_no":"29242190","bill_no":"7758446","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"MSN HOUSE, PLOT NO. C-24,, HYDERABAD. AP","customerAddress":""}]
05-Jan-2021
22-Feb-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Direct Compression

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Controlled & Modified Release

read-more
read-more

Granulation

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Taste Masking

read-more
read-more

Lubricants & Glidants

read-more
read-more

Co-Processed Excipients

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Solubilizers

read-more
read-more

Parenteral

read-more
read-more

Topical

read-more
read-more

Emulsifying Agents

read-more
read-more

Empty Capsules

read-more
read-more

API Stability Enhancers

read-more
read-more

Vegetarian Capsules

read-more
read-more

Coloring Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Zileuton Manufacturers

A Zileuton manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zileuton, including repackagers and relabelers. The FDA regulates Zileuton manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zileuton API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Zileuton manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Zileuton Suppliers

A Zileuton supplier is an individual or a company that provides Zileuton active pharmaceutical ingredient (API) or Zileuton finished formulations upon request. The Zileuton suppliers may include Zileuton API manufacturers, exporters, distributors and traders.

click here to find a list of Zileuton suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Zileuton USDMF

A Zileuton DMF (Drug Master File) is a document detailing the whole manufacturing process of Zileuton active pharmaceutical ingredient (API) in detail. Different forms of Zileuton DMFs exist exist since differing nations have different regulations, such as Zileuton USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Zileuton DMF submitted to regulatory agencies in the US is known as a USDMF. Zileuton USDMF includes data on Zileuton's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Zileuton USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Zileuton suppliers with USDMF on PharmaCompass.

Zileuton WC

A Zileuton written confirmation (Zileuton WC) is an official document issued by a regulatory agency to a Zileuton manufacturer, verifying that the manufacturing facility of a Zileuton active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Zileuton APIs or Zileuton finished pharmaceutical products to another nation, regulatory agencies frequently require a Zileuton WC (written confirmation) as part of the regulatory process.

click here to find a list of Zileuton suppliers with Written Confirmation (WC) on PharmaCompass.

Zileuton NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zileuton as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Zileuton API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Zileuton as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Zileuton and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zileuton NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Zileuton suppliers with NDC on PharmaCompass.

Zileuton GMP

Zileuton Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Zileuton GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zileuton GMP manufacturer or Zileuton GMP API supplier for your needs.

Zileuton CoA

A Zileuton CoA (Certificate of Analysis) is a formal document that attests to Zileuton's compliance with Zileuton specifications and serves as a tool for batch-level quality control.

Zileuton CoA mostly includes findings from lab analyses of a specific batch. For each Zileuton CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Zileuton may be tested according to a variety of international standards, such as European Pharmacopoeia (Zileuton EP), Zileuton JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zileuton USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty